A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61K 9/20 (2006.01) A61K 9/48 (2006.01) A61K 31/047 (2006.01) A61K 31/70 (2006.01) A61K 31/7004 (2006.01) A61K 31/704 (2006.01) A61K 31/715 (2006.01) A61K 47/10 (2006.01) A61K 47/26 (2006.01) A61K 47/36 (2006.01) A61P 29/00 (2006.01) A61P 35/00 (2006.01) A61P 37/00 (2006.01) C07H 5/06 (2006.01) C07H 15/20 (2006.01) C07H 15/244 (2006.01) C07H 15/252 (2006.01)
Patent
CA 2237450
A preparation comprising a glycosyl-Y[-C(=Y)-X-]p-W(R)n-X-C(=Y)-active compound,sugar or sugar alcohol and, if appropriate, divalent ions and a pharmaceuticallytolerable carrier has improved in vitro tolerability.
Une préparation renfermant un glycosyl-Y[-C(=Y)-X-]p-W(R)n-X-C(=Y)-composé actif, du sucre ou un itol et, si nécessaire, des ions divalents et un véhicule pharmacocompatible, possède une meilleure tolérabilité in vivo.
Blumrich Matthias
Bosslet Klaus
Czech Jorg
Gerken Manfred
Straub Rainer
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Hoechst Aktiengesellschaft
LandOfFree
Preparation having increased in vivo tolerability does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation having increased in vivo tolerability, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation having increased in vivo tolerability will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1803944